Is DNA flow cytometry a useful investigation in breast cancer?
- 31 March 1992
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (2-3), 504-507
- https://doi.org/10.1016/s0959-8049(05)80088-7
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Response to second-line hormone treatment for advanced breast cancer. Predictive value of ploidy determinationCancer, 1990
- Indicators of Prognosis in Node-Negative Breast CancerNew England Journal of Medicine, 1990
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- DNA ploidy and survival in breast cancer patientsCytometry, 1987
- Flow‐Cytometric DNA analysis in primary breast carcinomas and clinicopthological correlationsCytometry, 1984
- Ploidy Level of Human Breast Carcinoma Relation to Histopathologic Features and Hormone Receptor ContentActa Radiologica: Oncology, 1984